4/A//SEC Filing
FASS SIMCHA 4/A
Accession 0001218809-05-000002
CIK 0000722104other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 2:37 PM ET
Size
11.3 KB
Accession
0001218809-05-000002
Insider Transaction Report
Form 4/AAmended
FASS SIMCHA
Director
Transactions
- Award
Common stock, $.01 par value per share
2004-12-31$2.71/sh+1,383$3,748→ 226,902 total - Award
Options to purchase Common Stock, $.01 par value per share
2004-12-31$2.71/sh+5,000$13,550→ 9,347 totalExercise: $2.71From: 2005-12-31Exp: 2014-12-31→ Common Stock, $.01 par value per share (5,000 underlying)
Footnotes (3)
- [F1]These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On December 31, 2004, the fair market value of the Common Stock, based on the closing price, was $2.71.
- [F2]These options will become fully vested and immediately exercisable on 12/31/2005.
- [F3]This amendment to Form 4 filed on January 4, 2005 reflects the expiration of all options granted prior to Dr. Fass's retirement that were not exercised by the optionee within three (3) months of ceasing to be employed by the Company. Dr. Fass retired from his position as Chief Executive Officer of the Company as of July 12, 2004 and accordingly his timeframe to exercise options granted prior to July 12, 2004 expired on October 12, 2004.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001218809
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 2:37 PM ET
- Size
- 11.3 KB